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Pericytes induce formation of the blood-
brain barrier (BBB), but it is not clear why
only pericytes in the CNS have this unique
capability. Reyahi et al. identify the
forkhead transcription factor Foxf2 as
being expressed specifically in CNS
pericytes and as being required for BBB
formation and maintenance.
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Pericytes are critical for cerebrovascular maturation
and development of the blood-brain barrier (BBB),
but their role in maintenance of the adult BBB,
and how CNS pericytes differ from those of other
tissues, is less well understood. We show that the
forkhead transcription factor Foxf2 is specifically
expressed in pericytes of the brain and that Foxf2/
embryos develop intracranial hemorrhage, perivas-
cular edema, thinning of the vascular basal lamina,
an increase of luminal endothelial caveolae, and a
leaky BBB. Foxf2/ brain pericytes were more
numerous, proliferated faster, and expressed signif-
icantly less Pdgfrb. Tgfb-Smad2/3 signaling was
attenuated, whereas phosphorylation of Smad1/5
and p38 were enhanced. Tgfb pathway components,
including Tgfb2, Tgfbr2, Alk5, and integrins aVb8,
were reduced. Foxf2 inactivation in adults resulted
in BBB breakdown, endothelial thickening, and
increased trans-endothelial vesicular transport. On
the basis of these results, FOXF2 emerges as an
interesting candidate locus for stroke susceptibility
in humans.
INTRODUCTION
The demands on the vasculature vary widely among organs, and
the endothelium differs accordingly in characteristics such as
permeability to water, metabolites, macromolecules, and cells.
Genetic and co-culture experiments indicate that, rather than
being intrinsically different, endothelial cells adopt the pheno-
type specific to each tissue in response to their environment.
This is particularly well illustrated by the vasculature of the
CNS, where passive passage between the blood and the brain
parenchyma has been brought to a minimum. The intimately
connected cells of the neurovascular unit—astrocytes, micro-
glia, neurons, and mural cells (i.e., pericytes in capillaries and
vascular smooth muscle cells [vSMCs] in arteries)—tightly con-trol metabolite exchange, blood flow, and endothelial perme-
ability. This blood-brain barrier (BBB) minimizes intercellular
passage with tight junctions between endothelial cells and
non-specific trans-endothelial exchange by reduced vesicular
transport. Endothelial shuttling of metabolites is instead handled
by a range of selective transporters (Zlokovic, 2008).
Restriction of cerebrovascular permeability already occurs
during embryonic development, in mice about a week before
astrocyte differentiation and coincident with pericyte coloniza-
tion (Daneman et al., 2010). Loss of platelet-derived growth fac-
tor B (Pdgfb) in endothelium, or its receptor Pdgf receptor b
(Pdgfrb) in mural cells, inhibits proliferation andmigration of peri-
cytes and results in severe pericyte deficiency in many organs,
including the CNS (Leve´en et al., 1994; Lindahl et al., 1997; Sor-
iano, 1994). The phenotypes of hypomorphic alleles and gene
dosage alterations support a dose-response relationship be-
tween Pdgfb signaling and pericyte investment in the CNS and
show that vascular permeability correlates inversely with the de-
gree of pericyte coverage (Armulik et al., 2010; Daneman et al.,
2010).
In avian embryos, pericytes and vSMCs of the forebrain are
derived from cephalic neural crest, whereas those posterior of
the mesencephalon-prosencephalon boundary are mesodermal
(Etchevers et al., 2001; Korn et al., 2002; Kurz, 2009). The origin
of mammalian mural cells has not been as rigorously traced, but
marker analysis suggests that neural crest contributes most, if
not all, perivascular cells also in the posterior parts of the brain
(Armulik et al., 2011; Heglind et al., 2005). To what extent induc-
tion of BBB relies on unique properties of CNS pericytes is not
well understood, but lineage does not appear to be critical,
because mural cells of thymus and some craniofacial tissues
are derived from neural crest (Etchevers et al., 2001; Foster
et al., 2008), and avian CNS pericytes are of mixed origin.
In addition to Pdgfb/Pdgfrb, several paracrine and juxtacrine
pathways have been implicated in pericyte-endothelial signaling
(for a review, see Armulik et al., 2011). Tgfb is particularly pleio-
tropic and controls proliferation, migration, and differentiation of
both pericytes and endothelial cells (reviewed by Gaengel et al.,
2009; Winkler et al., 2011). Activation of latent Tgfb requires inti-
mate contact between the two cell types (Sato and Rifkin, 1989),
involving the gap junction protein connexin 43 (Hirschi et al.,
2003), and physical interaction with integrins aVb8 (Bader et al.,Developmental Cell 34, 19–32, July 6, 2015 ª2015 Elsevier Inc. 19
Figure 1. Expression of Foxf2 in Neural Crest-Derived Pericytes in the Brain
(A–D) Foxf2whole-mount in situ hybridization of mouse embryos. (A) Foxf2 expression in nascent neural crest. Dashed line indicates boundaries between surface
ectoderm, neural crest mesenchyme, and neuroectoderm. (B) Foxf2+ cells in head mesenchyme (asterisk) and associated with sprouting blood vessels
(arrowhead) in E10.5 hindbrain. (C) Foxf2+ cells in perineural mesenchyme surrounding E10.5 forebrain. (D) Profile of whole E11.5 head with Foxf2 expression
associated with the cranial vasculature.
(E) Foxf2 radioactive in situ hybridization (red) of E14.5 forebrain section with Foxf2+ expression in perineural mesenchyme and associated with the cerebral
vasculature.
(F) Detail from (E).
(legend continued on next page)
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1998; Cambier et al., 2005; Shi et al., 2011; Wipff and Hinz, 2008;
Zhu et al., 2002). The net effect of Tgfb signaling is determined by
the relative activities of two competing and antagonistic path-
ways, each mediated by a distinct type 1 receptor (Goumans
et al., 2002, 2003). Alk5-Smad2/3 increases production of extra-
cellular matrix of the vascular basal lamina, inhibits proliferation
and migration, and promotes differentiation of both endothelial
cells and pericytes. Alk1-Smad1/5 signaling has essentially the
opposite effect.
We describe the consequences for the brain vasculature of
targeting Foxf2, encoding a forkhead transcription factor.
Foxf2, and the closely related Foxf1, are expressed in tissues
derived from the splanchnic and head mesoderm, and have
partially overlapping roles in the development of endodermal
organs and the secondary palate (Astorga and Carlsson, 2007;
Mahlapuu et al., 2001a, 2001b;Wang et al., 2003). Foxf2 controls
gut development (Ormestad et al., 2006), a function conserved
between mammals and Drosophila (Jakobsen et al., 2007), and
is a mesenchymal regulator of the intestinal stem cell niche
(Nik et al., 2013). Foxf2 is also expressed in neural crest
(Ormestad et al., 2004), but the significance of this for embryonic
development has remained elusive. Here, we show that Foxf2-
expressing neural crest cells are progenitors of cerebrovascular
mural cells and that inactivation of Foxf2 leads to hyperplasia
and defective differentiation of brain pericytes, a leaky BBB,
and attenuation of Pdgfrb and Tgfb-Smad2/3 signaling.
RESULTS
Foxf2 Is Expressed in Neural Crest-Derived
Cerebrovascular Pericytes
Duringmurine embryonic development, Foxf2 expression is acti-
vated in neural crest (Figure 1A) around E9.5 (Ormestad et al.,
2004). At E10.5, Foxf2 mRNA is found in head mesenchyme
and is associated with the hindbrain vasculature (Figure 1B).
Foxf2 expression is also seen in the perineural mesenchyme
around the mid- and forebrain (Figure 1C) and is from E11.5
associated with blood vessels throughout the brain (Figures
1D–1F). This pattern is characteristic of neural crest-derived pro-
genitors of CNS mural cells, which migrate anteriorly/ventrally in
the perineural mesenchyme and enter the neuroectoderm along
the paths of the angiogenic sprouts that penetrate the devel-
oping brain from the surrounding vascular plexus (Daneman
et al., 2010; Heglind et al., 2005; Yamanishi et al., 2012). No
Foxf2 expression was seen associated with blood vessels
outside the brain (Figures 1B and 1E).
To confirm the identity of Foxf2-expressing cells, we immuno-
localized Foxf2 in the developing brain. The anti-Foxf2 antibody(G–L) Anti-Foxf2 (brown) and isolectin (blue) staining of cerebral cortex (G–J) and e
and K) and Foxf2/ (H, J, and L) E12.5 embryos (G and H: 403; I–L: 1003). D
parenchyma.
(M–P) Anti-Foxf2 (brown) staining of Foxs1lacZ/+, E12.5, forebrain sections (O an
neural crest cells in perineural mesenchyme (O) and in brain (insets in M and N)
(Q) Co-staining with anti-Foxf2 (DAB; brown) and anti-Pdgfrb (red fluorescence) i
visualize capillaries.
(R) Co-staining with anti-Foxf2 (DAB; brown) and anti-Lef1 (red fluorescence) in
visualize capillaries.
See also Figure S1.has a strong cross-reactivity with a pan-neuronal epitope (Nik
et al., 2013), which makes it inappropriate for use in the mature
brain, but until E12.5, the non-specific cytoplasmic staining re-
mains manageable. Foxf2+ nuclei were associated with blood
vessels (identified by isolectin staining) inside the brain (Figures
1G and 1I) but not in headmesenchyme (Figure 1K) and were ab-
sent from Foxf2/ embryos (Figures 1H, 1J, and 1L). In embryos
with a lacZ knockin allele of Foxs1, a neural crest marker that in
mid- and forebrain is expressed only in vascular mural cells (He-
glind et al., 2005), Foxf2 co-localized with the b-gal+ nuclei of
Foxs1lacZ-expressing cells, both in the perineural mesenchyme
(Figures 1Mand 1O) and in the brain (Figure 1M, inset). The spec-
ificity was verified by the absence of nuclear staining in sections
from Foxf2/ embryos (Figures 1N and 1P). Cells with Foxf2+
nuclei expressed Pdgfrb (Figure 1Q) but were negative for Lef1
(Figure 1R), a nuclear protein present in all endothelial cells in
the brain (Siegenthaler et al., 2013). Together, these results are
consistent with Foxf2-expressing cells in the embryonic brain
being pericytes and precursors of vSMCs.
Apart from the CNS, neural crest-derived pericytes also occur
in thymus (Foster et al., 2008). To investigate if Foxf2 expression
reflects lineage or is specific for CNS pericytes, we first
confirmed that the thymic vasculature contains cells of neural
crest origin by using mice transgenic for themTmG dual fluores-
cent marker (Muzumdar et al., 2007) and Wnt1-Cre (Danielian
et al., 1998), which gives neural crest-derived cells membrane-
localized enhanced GFP (EGFP) (green), whereas other cells
have tdTomato (red) fluorescence (Figure S1A available online).
Whereas Foxf2+ nuclei were detected in fibroblasts of intestinal
villi (Figure S1C) and along capillaries throughout the CNS,
including in the spinal cord (Figure S1D), no cells in the thymus
expressed Foxf2 (Figure S1B). Foxf2 is therefore a good candi-
date for a factor that distinguishes brain pericytes from those
of extra-neuronal tissues, independent of lineage.
Abnormal Cerebral Capillaries in Foxf2–/– Embryos
The gross morphology of the CNS vasculature was examined in
E18.5mTmG;Tie2-Cre, in which endothelial cells express EGFP.
No difference in angiogenesis (capillary density, branching fre-
quency) was detected between wild-type and Foxf2/ brains
(Figure S2A). In cross section, however, capillaries in Foxf2/
brains were thick walled with narrow lumina (Figures 2A–2C);
the average ratio of luminal to vessel circumference was 0.46,
compared with 0.82 in wild-type (p < 107; Figure 2C). Confocal
cross sections from mTmG;Wnt1-Cre brains revealed that an
increased investment with neural crest-derived (EGFP+) mural
cells was partly responsible for the increased capillary wall
thickness (Figure 2B). Transmission electron microscopy (TEM)xtra-neuronal (head mesenchyme) blood vessels (K and L) fromwild-type (G, I,
ashed lines in (G) and (H) indicate boundaries between meninges and brain
d P are magnifications of M and N). Foxf2 is localized to nuclei of lacZ+ (blue)
of Foxf2+/+ (M and O) but not Foxf2/ (N and P) embryos.
n E12.5 telencephalon. Erythrocyte (RBC) autofluorescence in green is used to
E12.5 telencephalon. Erythrocyte (RBC) autofluorescence in green is used to
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showed a thickened and irregular endothelium in Foxf2/ cap-
illaries (Figures 2D, 2E, and S2B), with the immature appearance
typical of growing vascular sprouts, rich in cytoplasm and mito-
chondria (Figures 2E and S2B). In normal capillaries, the basal
lamina that surrounds endothelium and pericytes appears as
an electron-dense layer of extracellular matrix between, and in
close contact with, cells of the neurovascular unit (Figures 2D
and 2F). In Foxf2/ brain, the basal lamina was highly variable:
normal in some regions but often thin, less electron dense, and in
some areas appeared to be missing altogether (Figures 2E, 2G,
and S2B). In its place, dilated extracellular spaces surrounded
the capillaries, indicative of perivascular edema (Figures 2E,
2G, and S2B). Immunohistochemistry (IHC; Figures 2H and 2I)
and western blot (Figure 2L) confirmed reduced amounts of
collagen IV around cerebral blood vessels in Foxf2/, whereas
themeningeal vasculature had a normal level (Figure S2E). Direct
signs of defective tissue integrity in Foxf2/ brains included an
elevated sensitivity to the stress inflicted by fixation and tissue
processing (Figure S2D) and an extremely rapid equilibration
during sucrose infusion prior to cryosectioning.
Junction complexes between capillary endothelial cells were,
on average, twice as long and more convoluted in Foxf2/,
compared with wild-type (Figures 2J, 2K, 2M, and S2C; p <
108; n = 40 wild-type and 34 Foxf2/). This may, however,
be an inevitable consequence of the thicker and more irregular
endothelial cells rather than an independent trait.
Brain Pericyte Number Correlates Negatively with Foxf2
Gene Dosage
The fraction of the capillary endothelial surface covered by peri-
cytes in Foxf2/ brains was approximately twice that in wild-
type, as judged from E18.5 mTmG;Wnt1-Cre (Figures 2N–2P;
69% versus 33%; p = 104). Larger blood vessels were not
studied systematically, but a cursory examination suggested a
corresponding increase in mural cell investment (Figure S2F).
X-gal staining of Foxs1lacZ embryos showed an increased den-
sity of b-gal+ cells associated with cerebral blood vessels in
Foxf2/, without alterations in other neural crest populations
(Figures 2Q and 2R). The impact of Foxf2 gene dosage on muralFigure 2. Cerebrovascular Histology and Ultrastructure of Foxf2–/– Em
(A) Cross sections of capillaries in the cerebral cortex of E18.5 wild-type (top) an
(B) Cross sections of capillaries in the cerebral cortex of E18.5 wild-type (top) and
crest-derived vascular mural cells are green, endothelial membranes bright red,
(C) Cross section morphometry of E18.5 cerebral cortex capillaries from wild-typ
(p < 102), and smaller ratio of luminal to outer perimeter (p < 107) in Foxf2/ c
(D–G) TEM of cross sections of E18.5 cortical capillaries showing thickened e
arrowheads), and gaps of extracellular space (white arrowheads) in Foxf2/ (E an
1 mm (F and G). For additional examples of Foxf2/ capillaries, see Figure S2B.
(H and I) Anti-collagen IV IHC (brown) of E18.5 cerebral cortex from wild-type
fluorescence (green) is used to visualize capillaries. For additional collagen IV IH
(J and K) Inter-endothelial junctions (black arrows) in wild-type (J) and Foxf2/ ca
junctions, see Figure S2C.
(L) Collagen IV western blot (b-actin as loading control) of E18.5 wild-type and F
(M) Average lengths of inter-endothelial junctions in cross sections of wild-ty
Error bars = SEM.
(N) Pericyte coverage of forebrain capillaries based on confocal images of E18.5
(O and P) Cerebral cortex capillaries at three different magnifications fromE18.5m
bright red, and other cells dull red.
(Q and R) Distribution and abundance of neural crest cells visualized by Foxs1lac
See also Figure S2.cell density in different parts of the brain was quantified at several
developmental stages from sections of Foxs1lacZ embryos (Fig-
ures 3A–3H and S3A and S3B). At E11.5, the number of intra-
cerebral b-gal+ cells was few and the difference between
Foxf2/ and wild-type was not statistically significant, although
the mutants had on average 4-fold more Foxs1+ cells (Fig-
ure S3A). One day later, E12.5, Foxf2/ brains had 4.5-fold
more b-gal+ cells (Figures 3A–3C; p = 103), and at E18.5, the
difference was 1.9-fold (Figure 3H; p < 106). We also analyzed
the Tg(FOXF2) transgenic strain, which carries a single-copy
insertion of a BAC clone containing the human FOXF2 gene
and 115 kb of flanking sequence (Nik et al., 2013). This trans-
gene, which can rescue the lethal Foxf2/ phenotype, induces
an overexpression of FoxF2 of approximately 50% (in intestinal
mesenchyme; Nik et al., 2013). Strikingly, the b-gal+ cell density
depended almost linearly on Foxf2 gene dosage (ANOVA p <
1012) in mutants with both higher and lower than normal allele
number: E18.5 Tg(FOXF2) had 68% of the wild-type density
(p < 103), heterozygotes were intermediate between wild-type
and Foxf2/, and Foxf2/ rescued by Tg(FOXF2) was compa-
rable with Foxf2/+ (144%and 137%, respectively; Figure 3H). At
all developmental stages, the difference in Foxs1+ cell density
between Foxf2/ and wild-type was similar along the rostro-
caudal axis of the brain (Figure S3A), consistent with the higher
count in the knockout representing an increase in cell number,
rather than faster migration leading to more rapid colonization
of the anterior brain vasculature.
Increased Proliferation and Defective Differentiation of
Foxf2–/– Pericytes
The increased density of cerebral vascular mural cells in
response to Foxf2 inactivation suggested that Foxf2 negatively
regulates their proliferation. To address this, we exposed fe-
males pregnant with Foxs1lacZ/+ litters to a BrdU pulse and
compared the fraction of intra-cerebral b-gal+ cells that were
BrdU+ between Foxf2/ and wild-type littermates (Figures 3I–
3K and S3C). At E12.5, Foxf2 inactivation increased BrdU+ cells
from 23% in wild-type to 32% in Foxf2/ (p = 0.002) and at
E18.5 from 28% to 41% (p = 0.002). A similar result was obtainedbryos
d Foxf2/ (bottom) mice.
Foxf2/ (bottom) mice onmTmG;Wnt1-Cre background. Membranes of neural
and other cells dull red.
e and Foxf2/ mice, showing smaller lumina (p < 103), thicker vascular walls
apillaries. Error bars = SEM, n = 8 per genotype.
ndothelium (en), shrunken lumen (lu), poorly developed basal lamina (black
d G). er, erythrocyte; pe, pericyte. The scale bars represent 2 mm (D and E) and
(H) and Foxf2/ (I) mice at 203 (top) and 403 (bottom). Erythrocyte auto-
C, see Figure S2E.
pillaries (K). The scale bars represent 0.5 mm. For additional examples of EC-EC
oxf2/ brains.
pe and Foxf2/ capillaries. p < 108; n = 40 wild-type and 34 Foxf2/.
mTmG;Wnt1-Cre brains. p = 104; n = 6 per genotype; error bars = SEM.
TmG;Wnt1-Cre, wild-type and Foxf2/mice. Pericytes are green, endothelium
Z (blue) in E12.5 wild-type and Foxf2/ embryos.
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with the proliferation marker PCNA at E18.5 (Figures S3D and
S3E; p < 103; 19%PCNA+ in wild-type versus 42% in Foxf2/).
Elevated proliferation can thus account for the increased peri-
cyte density in Foxf2/ brain.
Next, we investigated how Foxf2 deletion affected brain peri-
cyte differentiation. IHCwith anti-Pdgfrb on Foxf2/ E18.5 brain
showed a normal pattern in the meningeal vasculature but very
weak staining of the capillaries in the brain parenchyma (Figures
3L and 3M). On mTmG;Wnt1-Cre background, anti-Pdgfrb co-
stained with the green fluorescence of brain pericytes in wild-
type but was barely detectable in the Foxf2/ mutant (Figures
3N and 3O). Western blot with brain extracts that included the
meninges showed a moderate decrease of Pdgfrb in the Foxf2
mutant (66 ± 12% of wild-type), whereas in samples in which
the meninges had been removed, the difference was more pro-
nounced (Foxf2/ 17 ± 3% of wild-type; Figure 3P). qPCR indi-
cated that Foxf2/ brain (without meninges) had less than 20%
of the wild-type level of Pdgfrb mRNA, in spite of possession
of almost twice the number of pericytes (Figure 3Q; p < 105).
Other pericyte markers were less affected; Tem1 was present
at 69 ± 9% of wild-type level (Figure S3F), whereas the amount
of Ng2 was unaltered (Figure S3G) in extracts of Foxf2/ brains.
Expression of desmin was delayed in the Foxf2mutant; at E13.5,
anti-desmin staining of brain capillaries was significantly weaker
in Foxf2/ than in wild-type, whereas the E18.5 patterns were
comparable (Figure S3H).
Intracranial Hemorrhage and Defective BBB in Foxf2–/–
Embryos
From E12.5, many Foxf2/ embryos exhibited variable degrees
of intracranial hemorrhage (ICH; Figures 4A and 4B), and TEM re-
vealed microbleeds in the form of scattered extravascular eryth-
rocytes in the brain parenchyma (Figure S4A).
To assess the integrity of the BBB, we used intraperitoneal in-
jections of the tracer Evans blue on E18.5 fetuses in utero. Evans
blue binds avidly to serum albumin, and its accumulation in the
brain indicates albumin leakage from the vasculature due to
breakdown of the BBB (Hawkins and Egleton, 2006). Three hours
after injection, Foxf2/ brains had widespread blue staining
(Figure 4D). The distribution and intensity varied among individ-
uals but were in all cases clearly distinguishable from the un-Figure 3. Increased Proliferation and Defective Differentiation of Brain
(A and B) Sections of E12.5 telencephalon with perineural mesenchyme from
background.
(C) Relative density of b-gal+ nuclei in brains of E12.5 wild-type and Foxf2/ em
(D–G) Sections of E18.5 cerebral cortex from X-gal stained wild-type (D and F), F
(H) Relative density of b-gal+ nuclei in brains of E18.5mice with different Foxf2 gen
(Foxf2/+ versus Foxf2/), p < 106 (Foxf2/ versus WT), p < 103 (Foxf2/;
3 Foxf2/;Tg[FOXF2].
(I and J) BrdU (brown) labeling of S-phase nuclei in E12.5 wild-type (I) and Foxf2
nuclei; white for BrdU– and black for BrdU+.
(K) Fraction of b-gal+ nuclei in brain that are BrdU+ at E12.5 (left) and E18.5 (right) i
type versus 32% in Foxf2/, p = 0.002, n = 7 per genotype; E18.5: 28% BrdU+
(L and M) Anti-Pdgfrb IHC on sections of cerebral cortex from wild-type (L) and
capillaries. me = meninges.
(N and O) Anti-Pdgfrb IF (blue) on cerebral cortex capillaries from wild-type (N) an
bright red, and other cells dull red.
(P) Pdgfrb western blots (b-actin as loading control) with extracts made from E18
(Q) Pdgfrb mRNA (two splice versions; by qPCR) in E18.5 wild-type and Foxf2/
Error bars in (C), (H), (K), and (Q) = SEM. See also Figure S3.stained brains of wild-type littermates (Figure 4C). On average,
Foxf2/ brains held 224% of the amount of Evans blue retained
in wild-type, on the basis of spectrophotometric quantification of
whole brain extracts (Figure 4E; p < 104), and were 10%
heavier, suggestive of cerebral edema, but the latter difference
was not statistically significant (p = 0.07).
Decreased Tgfb Signaling in Foxf2–/– Brain Vasculature
Tgfb signaling is essential for many aspects of vascular develop-
ment, including differentiation of endothelial and mural cells and
production of the extracellular matrix of the vascular basal lam-
ina (Gaengel et al., 2009). Inhibition of this pathway by targeting
Smad4 in cerebrovascular endothelial cells caused defects
similar to the Foxf2/ phenotype described here, including
ICH and BBB breakdown (Li et al., 2011). We therefore
compared canonical Tgfb signaling, measured as Smad2/3
phosphorylation (P-Smad2/3), in E18.5 Foxf2/ and wild-type
brains. The amount of Smad2/3 protein was not altered, but
the level of P-Smad2/3 was significantly reduced in the
mutant (Figures 4F and 4G). IHC with phospho-specific anti-P-
Smad2/3 showed activated Smad2/3 to be associated with cap-
illaries, to be less abundant in the Foxf2mutant, and not detected
in Foxs1lacZ-positive pericytes (Figure 4F). Cell-type-specific
loss-of-function phenotypes indicate that the Alk5-Smad2/3
pathway is active in endothelial cells and vSMCs, whereas the
status in pericytes is disputed (reviewed by Gaengel et al.,
2009). Our inability to detect P-Smad2/3 in Foxs1lacZ+ pericytes
of either genotype (Figure 4F) may be due to limitations in sensi-
tivity but suggests that the concentration in endothelial cells is
significantly higher.
The amounts of the Tgfb ligand Tgfb2, the type 2 receptor
Tgfbr2, and the type 1 receptor Alk5 were all reduced in Foxf2/
brain, at the protein and/or mRNA level (Figures 4G and 4H),
whereas the levels of Tgfb1, Tgfb3, and Tgfbr3 were normal (Fig-
ures S4B and S4C). Tgfb signaling through Alk5 and Smad2/3
has an antagonistic relationship to the Alk1-Smad1/5 pathway
(Goumans et al., 2002), as well as to the non-canonical path-
way mediated by p38 (Iwata et al., 2012). Consistent with the
reduction in P-Smad2/3, phosphorylation of both Smad1/5
and p38 were increased in Foxf2 mutant brain (Figure 4G). No
change in expression of the Smad phosphatase Ppm1a wasPericytes in Foxf2–/– Embryonic Brain
X-gal stained wild-type (WT) (A) and Foxf2/ (B) embryos on Foxs1lacZ/+
bryos on Foxs1lacZ/+ background. p = 103, n = 3 per genotype.
oxf2/ (E) and Tg(FOXF2) (G) embryos on Foxs1lacZ/+ background.
otype. p < 103 (Tg(FOXF2) versusWT), p < 104 (Foxf2/+ versusWT), p < 104
Tg[FOXF2] versus Foxf2/). n = 8 WT, 4 Tg[FOXF2], 5 Foxf2/+, 3 Foxf2/,
/ (J) embryos on Foxs1lacZ/+ background. Arrowheads indicate b-gal+ (blue)
n wild-type and Foxf2/ on Foxs1lacZ/+ background (E12.5: 23%BrdU+ inwild-
in wild-type versus 41% in Foxf2/, p = 0.002, n = 3 per genotype).
Foxf2/ (M) E18.5 brains at high and low magnification. Arrowheads indicate
d Foxf2/ (O) E18.5mTmG;Wnt1-Cremice. Pericytes are green, endothelium
.5 brains (wild-type and Foxf2/) with or without meninges.
 brain (meninges removed; p < 105; n = 6 per genotype).
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detected (Figure S4B), which is compatible with the reduction in
P-Smad2/3 being the result of decreased phosphorylation,
rather than increased de-phosphorylation, and fits the notion
of diminished signaling by Alk5/Tgfbr2.
Integrins are important for activation of latent extracellular Tgfb
complexes, andgenetic ablationof integrinaVorb8 causesdefec-
tive angiogenesis associated with attenuated Tgfb signaling
(Arnold et al., 2014; Bader et al., 1998; Cambier et al., 2005;
Zhu et al., 2002). qPCR showed significantly reduced mRNA
levels for both chains of the dominating integrin in CNS vascula-
ture, aVb8 (Figure 4H; Itga5, 32% of wild-type, p < 0.001; Itgb8,
43%ofwild-type, p=0.002). IntegrinaVprotein levelwas reduced
correspondingly (Figure 4G), and integrin b1 also showed a
modest reduction of bothmRNAandprotein (Figures 4G and4H).
The G protein-coupled receptor Gpr124 is both a target and a
regulator of Tgfb signaling; Gpr124-knockout mice have cere-
brovascular defects associated with perturbed Tgfb pathway
activation, and Tgfb increases Gpr124 expression (Anderson
et al., 2011). Consistent with the diminished Smad2/3 phosphor-
ylation, Gpr124 mRNA in Foxf2/ brains was reduced to less
than half the wild-type level (Figure 4H; p = 0.01).
mRNA for other proteins known to be important in angiogen-
esis, or cross-talk between pericytes and endothelial cells,
such as angiopoietins 1 and 2 (Angpt1, Angpt2), vascular endo-
thelial growth factor A (Vegfa), and connexins 43 and 45 (Gja1,
Gjc1), was not significantly altered in the Foxf2mutant brain (Fig-
ure S4B). Neither was the mRNA level for Foxc1 (Figure S4B), a
related forkhead gene located 175 kb from Foxf2, which is ex-
pressed in the brain vasculature and important for its develop-
ment (Siegenthaler et al., 2013).
The tight association between astrocytes and the vasculature
does not develop until postnatally (Daneman et al., 2010), but
already at E18.5 aquaporin 4, an astrocyte marker, is enriched
along brain capillaries (Figures S4D and S4E). In Foxf2/ brains,
aquaporin 4 staining was diffuse and not obviously associated
with the vasculature, although the amount of protein (Figure S4C)
and mRNA (97 ± 12% of wild-type; n = 14 per genotype) was
normal.
Increased Trans-endothelial Vesicular Transport in
Foxf2–/– Brains
Endothelial cells of Foxf2/ brain capillaries contained abun-
dant cytoplasmic vesicles, which suggested increased vesicleFigure 4. Foxf2–/– Brains Have a Leaky BBB and Reduced Tgfb Signali
(A and B) ICH in E13.5 Foxf2/ (B) embryo, with wild-type littermate (A) for com
(C and D) Evans blue leakage into E18.5 Foxf2/ (D), but not wild-type (C), brain
(E) Quantification of Evans blue in E18.5 brains. Foxf2/ brains contained on av
12 wild-type.
(F) Anti-phospho-Smad2/3 IHC (brown) and X-gal staining (blue) of sections
background.
(G) Western blots with brain extracts from E18.5 wild-type and Foxf2/ mice.
(H)mRNA (by qPCR) for proteins involved in Tgfb signaling in E18.5 Foxf2/ brain
45%, p = 0.01; Itga5 32%, p < 0.001; Itgb1 69%, p = 0.1; Itgb8 43%, p = 0.002;
(I and J) Low (top) and high (bottom) magnification TEM images of brain capillary
(J) than in wild-type (I). The scale bars represent 1 mm (top) and 100 nm (bottom
(K) Number of luminal caveolae (average 1.95/capillary in wild-type versus 7.13 i
(L and M) TEM images of DAB-stained brain tissue from adult wild-type (L) and
endothelial cells of Foxf2/fl mutants have DAB+ caveolae and vesicles (arrowhe
Error bars in (E), (H), and (K) = SEM. See also Figure S4.mediated trans-cytosis, and high magnification of the luminal
endothelial membrane revealed an increased density of caveo-
lae (Figures 4I–4K and S4F; 7.13/capillary in Foxf2/ versus
1.95 in wild-type; p < 0.01).
To investigate if these vesicles transported luminal content
across the endothelium required a tracer observable by TEM
and the ability to do experiments in postnatal mice. We gener-
ated a conditional allele of Foxf2 (Foxf2fl; Figure S4G) in which
loxP sites flank the first exon, and combined it with inducible
CAGG-CreERT2 (Hayashi and McMahon, 2002). Inactivation of
Foxf2 in adult Foxf2fl/ and Foxf2fl/fl mice by tamoxifen led to a
gradual increase in brain vascular permeability (see next sec-
tion). Intravenous injection with horseradish peroxidase (HRP)
15 min before euthanasia and perfusion fixation, followed by
diaminobenzidine (DAB) staining and TEM, showed DAB precip-
itates in caveolae and vesicles of Foxf2fl/ endothelial cells (Fig-
ure 4M). The occurrence of DAB+ vesicles next to the abluminal
membrane indicated trans-endothelial transport of HRP. No
accumulation of DAB precipitates was observed in junctions be-
tween endothelial cells, which suggests that increased vesicular
transport is the principal factor behind the vascular permeability
in Foxf2 mutant brains.
Foxf2 Is Required for Maintained BBB in Adult Mice
The role of pericytes in establishment of the BBBduring develop-
ment has been clearly demonstrated, but their importance for
maintenance of vascular integrity has been questioned, and
the relative contribution of pericytes and astrocytes for perme-
ability regulation in the adult CNS vasculature remains unclear
(Armulik et al., 2010; Daneman et al., 2010). We therefore asked
whether persistent Foxf2 expression is required to uphold BBB
integrity, or if it is dispensable once the vasculature hasmatured.
Conditional knockouts (Foxf2fl/fl and Foxf2fl/) responded to
tamoxifen-induced Foxf2 deletion with weight loss, rapid during
the first month and then more slowly (Figure S5A). The mortality
of Foxf2fl/fl was 40% during the first 6 weeks after Cre induction,
whereas all other genotypes, including Foxf2fl/, had normal sur-
vival. BBB integrity was not significantly affected during the first
3 weeks after Foxf2 deletion. However, after 6 weeks, the
average Evans blue retention in Foxf2fl/ brains was >4-fold
higher than in wild-type, Foxf2fl/+ (p < 1010), or heterozygotes
(p < 106), and the mutant brains turned distinctly blue (Figures
5A, 5B, S5B, and S6). Surprisingly, Foxf2fl/fl brains had evenng
parison.
.
erage 2.24-fold more Evans blue than wild-type; p < 104, n = 9 Foxf2/ and
of cerebral cortex from E18.5 wild-type and Foxf2/ mice on Foxs1lacZ/+
(as percentage of wild-type): Tgfb2 60%, p = 0.002;Alk5 57%, p < 0.02;Gpr124
n = 6 per genotype.
endothelium showing more luminal caveolae (arrowheads) in Foxf2/ mutants
).
n Foxf2/; n = 8 per genotype; p < 0.01).
Foxf2/fl;CAGG-Cre (M) mice injected with HRP 15 min before perfusion. The
ads) present on both luminal (left image) and abluminal (right image) sides.
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more damaged barrier function and held on average 8-fold more
tracer than Foxf2fl/+ (Figures 5A and 5B; p < 108 versus Foxf2fl/+
and p < 0.05 versus Foxf2fl/). Neither Foxf2/+ heterozygotes
(111%) nor knockout mice rescued by the Tg(FOXF2) transgene
(Foxf2/;Tg[FOXF2]; 104%) differed significantly from wild-type
or Foxf2fl/+ (100%).
Differences in pericyte number, measured as b-gal+ cell den-
sity in Foxs1lacZ/+ cerebral cortex, as a function of Foxf2 gene
dosage was similar in adult mice to that of E18.5: Tg(FOXF2)
had less (77%; p < 102) and Foxf2/+ more (160%; p < 104)
than wild-type (100%; Figure 5C). No dramatic increase in peri-
cyte density occurred in response to Foxf2 inactivation in adults:
after 6 weeks, Foxf2fl/fl did not differ significantly from wild-type
(117% versus 100%; p = 0.12) and Foxf2fl/ not from Foxf2/+
(181% versus 160%; p = 0.22; Figure 5C). The negative correla-
tion between pericyte density and Foxf2 gene dosage is thus
established during development and is not or little affected by
Foxf2 inactivation in adulthood. The difference in pericyte num-
ber between Foxf2fl/ and Foxf2fl/fl presents a possible explana-
tion for why the latter suffered higher mortality and leakier BBB,
even though Foxf2 loss is expected to be more complete in the
former. During development, Foxf2fl/ establishes a significantly
higher pericyte density than Foxf2fl/fl, which may partially protect
against defective pericyte function later on when Foxf2 is
deleted.
The reduced number of pericytes in Tg(FOXF2), with three
functional copies of the gene, confirms that the negative correla-
tion between Foxf2 allele number and density of cerebral peri-
cytes is evident at all ages, embryonic and adult, and in animals
with both increased and decreased gene dosage. Interestingly,
but consistent with the correlation between pericyte coverage
and vascular permeability, Tg(FOXF2) brains had a modest
(60%) but highly reproducible (p < 103) increase in Evans blue
permeability (Figure S5C).
Foxf2 inactivation in adults had a similar effect on Pdgfrb as in
embryos, with reduced immunoreactivity of cortical capillaries
(Figures 5D and 5F) but persistent expression level in meninges
(Figure S5D). In contrast, no alteration in desmin, Vegfa, or aqua-
porin 4 was observed (Figures S5E–S5G). Smad2 level was not
affected, but its phosphorylation was reduced, as was the level
of Tgfbr2 (Figure 5D). mRNA quantifications suffered from inter-
individual variation, and none of the genes involved in TgfbFigure 5. BBB Breakdown upon Inactivation of Foxf2 in Adult Mice
(A and B) Images (A) and quantification (B) of Evans blue retention in brains of mic
(Foxf2/fl versus Foxf2/+); p < 0.05 (Foxf2/fl versus Foxf2fl/fl); p < 104 (Foxf2/fl
not significantly different from Foxf2+/fl (100%). n = 12 Foxf2/+, 8 Foxf2/+, 9 Fo
(C) Relative density of b-gal+ nuclei in brains of Foxs1lacZ/+ mice with different Fox
p < 104 (Foxf2/fl versus WT); p = 0.02 (Foxf2/fl versus Foxf2fl/fl); p = 0.03 (Fox
(160%), and Foxf2fl/fl (117%) not significantly different from WT (Foxf2+/+, 100%)
(D) Western blots with brain extracts from adult Foxf2/fl and Foxf2+/fl mice.
(E) mRNA (by qPCR) for proteins involved in Tgfb signaling in adult Foxf2/fl brai
(F) Anti-Pdgfrb IHC of cerebral cortex from Foxf2/fl and Foxf2+/fl mice. Arrowhea
(G) Increased number of luminal caveolae (arrowheads) in brain capillary endoth
(H) Cross sections of cerebral cortex capillaries from Foxf2/fl and Foxf2+/fl mice s
pericyte (white arrowheads) nuclei (asterisk in Foxf2/fl). The scale bars represen
(I) Inter-endothelial junction length (junct), luminal caveolae density (cav), luminal a
from TEM images of capillary cross sections from cerebral cortex (n = 50 section
endothelial cell area).
Error bars = SEM in (B) (linear representation of SEM of log values), (C), (E), andsignaling showed a significant difference. The trend, however,
was the same as in Foxf2/ embryos, with less mRNA for
Itga5, Alk5, and Tgfbr2 (Figure 5E).
TEM analysis of cortical capillaries revealed that Foxf2 inacti-
vation resulted in a 2.4-fold increase in luminal caveolae (Figures
5G and 5I; p < 104), lengthening of inter-endothelial junctions
(Figure 5I; p < 105), and a thickening of the endothelium by
approximately 50% (Figures 5H and 5I; p < 0.01; n = 50 cross
sections per genotype). No significant differences were
observed in capillary density (Figure S5H) or in overall vessel di-
mensions or shape parameters (Figure S5I). We also scored the
sections for the presence or absence of pericyte nuclei and
noted a doubling of the frequency, from 5.7% in Foxf2fl/+ to
12.2% in Foxf2fl/ (p < 0.05; n = 141 Foxf2fl/+ cross sections
and 131 Foxf2fl/). The higher frequency of pericyte nuclei
is consistent with the 1.8-fold increase in b-gal+ cells in
Foxf2fl/;Foxs1lacZ/+ (Figure 5C).
Taken together, these results demonstrate that persistent
Foxf2 expression is required to maintain the barrier function in
the mature cerebral vasculature. Adult inactivation of Foxf2 did
not cause the severe structural defects observed as a result of
Foxf2 deficiency during development but increased vascular
permeability significantly.
DISCUSSION
The next neighbor of FoxF2 in the genomes of mice and man—
FoxC1, encoding another forkhead transcription factor and
located approximately 200 kb downstream of FoxF2—is ex-
pressed in the brain vasculature and influences vessel morpho-
genesis and proteoglycan expression (Siegenthaler et al., 2013).
Foxc1 inactivation did not affect the BBB, Pdgfrb, or Tgfb
signaling (Siegenthaler et al., 2013) and is therefore mechanisti-
cally distinct from that of Foxf2. Murine Foxc1 mutants had
increased proliferation of both endothelial cells and pericytes,
whereas FoxC1 knockdown in zebrafish was reported to impair
recruitment of mural cells and neural crest migration (French
et al., 2014). Deletion of Foxf2 did not affect expression of
Foxc1; a transgenic strain with increased FoxF2 gene dosage,
Tg(FOXF2), has a phenotype opposite that of the Foxf2
knockout; and transgenic rescue of Foxf2/ by Tg(FOXF2) pro-
duced a phenotype indistinguishable from the heterozygote.e with different Foxf2 genotype. p < 1010 (Foxf2/fl versus Foxf2+/fl); p < 106
versus Tg[FOXF2];Foxf2/). Foxf2/+ (111%) and Tg(FOXF2);Foxf2/ (104%)
xf2/fl, 5 Foxf2fl/fl, and 3 Tg(FOXF2);Foxf2/.
f2 genotype. p = 0.007 (Tg[FOXF2] versus WT); p < 104 (Foxf2/+ versus WT);
f2/+ versus Foxf2fl/fl). Foxf2/fl (181%) not significantly different from Foxf2/+
. n = 3 Tg(FOXF2), 8 WT, 8 Foxf2/+, 7 Foxf2/fl, and 3 Foxf2fl/fl.
n (as percentage of Foxf2+/fl); n = 5 per genotype.
ds indicate capillaries.
elium of Foxf2/fl. The scale bars represent 0.5 mm.
howing thickening of endothelium (black arrowheads) and increased number of
t 1mm.
rea (lum), and endothelial cell area (ec) of Foxf2/fl relative to Foxf2+/fl quantified
s per genotype; p < 105 for junctions, p < 104 for caveolae, and p = 0.005 for
(I). See also Figures S5 and S6.
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Together, these observations strongly support the notions that
deletion of Foxf2 does not affect Foxc1, and the Foxf2 knockout
phenotype is not a result of perturbed Foxc1 expression.
Foxf2 deficiency increases rather than decreases pericyte
density. The mechanism underlying BBB breakdown is therefore
qualitatively different from that of Pdgfb/Pdgfrb mutants and
likely to represent a differentiation defect in pericytes that indi-
rectly affects the endothelium. Two of the major paracrine
signaling pathways involved in pericyte-endothelial communica-
tion are affected: Pdgfb/Pdgfrb and Tgfb. Signaling in endothelial
cells and pericytes are highly entangled, and perturbations of the
Tgfb pathway tend to result in similarmolecular and phenotypical
signatures, independent of where the primary defect resides. To
aid in mechanistic understanding, work is in progress to identify
Foxf2 target genes and to separate endothelial from pericyte
gene expression alterations.
The increased pericyte density, in spite of less Pdgfrb in
Foxf2/mutants, contradicts the firmly established requirement
for Pdgfb and its receptor for recruitment of pericytes to the brain
vasculature. Because of the residual Pdgfrb expression in
Foxf2/ brain (estimated to 10%), Pdgfrb may still be essential
for guiding CNS pericyte migration, but the robust mural cell in-
vestment throughout the cerebrovascular tree in Foxf2 mutants
suggests that other cues are used. The existence of such alter-
native mechanisms for pericyte recruitment is illustrated by the
Pdgfb/Pdgfrb independent colonization by hepatic stellate cells
(Hellstro¨m et al., 1999), and the neural crest-derived pericytes of
the thymus (Foster et al., 2008). The requirement for Pdgfrb
signaling for pericyte proliferation is apparently lost in the
absence of Foxf2.
Increased pericyte proliferation is consistent with the
observed reduction in Smad2/3 phosphorylation and the corre-
sponding increase in P-Smad1/5; Tgfb signaling through Alk5-
Smad2/3 promotes differentiation and inhibits proliferation of
both endothelial cells and pericytes, whereas Alk1-Smad1/5
does the opposite (Armulik et al., 2011; Winkler et al., 2011).
Other phenotypic traits in Foxf2 mutants characteristic of
attenuated vascular Tgfb are extracellular matrix deficiency,
vascular immaturity, and ICH (Li et al., 2011). The reduced levels
of Tgfb2, Alk5, Tgfbr2, and Gpr124 are likely to contribute to
the weaker signaling, as are decreased amounts of integrins aV
and b8, which are important for activation of latent Tgfb (Cambier
et al., 2005; Shi et al., 2011; Wipff and Hinz, 2008). Gpr124
and vascular integrins are also targets of Alk5-Smad2/3, and
the lowered expression may therefore both contribute to, and
be a consequence of, diminished Smad2/3 phosphorylation.
Interestingly, recent data (Arnold et al., 2014) indicate that loss
of integrins aVb8 leads to cerebral hemorrhage and vascular
dysplasia with intact BBB, whereas Pdgfbret/ret have essentially
the opposite phenotype, with BBB disruption, but no hemor-
rhage. This suggests that in Foxf2mutants the diminished Pdgfrb
is responsible for BBB breakdown, whereas reduction in Tgfb
and integrin expression may lead to vascular instability and
hemorrhage.
CNS pericytes have been shown to be required for establish-
ment of the BBB during embryonic development at a stage that
precedes astrocytic endfeet integration into the neurovascular
unit (Daneman et al., 2010). Amodel has been proposed in which
the maintenance of BBB integrity is taken over by the astrocytes30 Developmental Cell 34, 19–32, July 6, 2015 ª2015 Elsevier Inc.as the vasculature matures, leaving the pericytes obsolete
(Daneman et al., 2010). Inactivation of Foxf2 in adult mice led
to a gradual increase in vascular permeability over a period of
several weeks. The slow kinetics suggests that the link between
Foxf2 in pericytes and regulation of endothelial permeability con-
tains components that are turned over slowly and possess a fair
amount of buffering capacity, perhaps involving reciprocal
signaling between several cell types. However, it is clear that
continued presence of properly differentiated pericytes is essen-
tial for maintenance of the BBB also in the adult. The histological
consequences of Foxf2 deficiency were subtler than during em-
bryonic development, but the endothelium became thicker and
vascular permeability increased significantly.
Higher than normal gene dosage of Foxf2 produced a pheno-
type that mirrored the loss of function, with decreased brain
pericyte density. Whereas loss of function resulted in a leaky
vasculature with an excess of defective pericytes, a 50% in-
crease in FoxF2 gene dosage reduced pericyte density, which
led to the expected increase in permeability. Importantly, wild-
type Foxf2 gene dosage provides the tightest brain vasculature.
The sensitivity to altered Foxf2 expression level suggests that
genetic alterations that affect the regulation, or copy number, of
the human FOXF2 gene could predispose to cerebrovascular
disease and stroke. Interestingly, several reports have linked
whitematter abnormalities and stroke to copy-number variations
in the relevant chromosomal region, 6p25 (Cellini et al., 2012;
Kapoor et al., 2011; Rosenberg et al., 2013; van der Knaap
et al., 2006; Vernon et al., 2013). Interpretations are complicated
by the fact that FOXC1 are located only 214 kb downstream
(centromeric) of FOXF2, and recently genetic variants centro-
meric of FOXC1 were associated with white matter hyperinten-
sities (French et al., 2014). Work is in progress to determine to
what extent genetic variation in human FOXF2 affects the risk
to suffer a stroke and to distinguish the relative contributions of
FOXF2 and FOXC1 to 6p25-stroke associations.
EXPERIMENTAL PROCEDURES
Mouse Strains
For construction of the constitutive (Foxf2) and conditional (Foxf2fl) Foxf2 null
alleles, see Supplemental Experimental Procedures. To ensure that the
observed knockout phenotype was allele independent, key experiments
were repeated with a Foxf2 allele kindly provided by Dr N. Miura (Wang
et al., 2003).
The Tg(FOXF2) transgenic strain and rescue of the null allele by this trans-
gene has been described elsewhere (Nik et al., 2013). mTmG (Muzumdar
et al., 2007), Wnt1-Cre (Danielian et al., 1998), Tie2-Cre (Kisanuki et al.,
2001), and CAGG-CreERT2 (Hayashi and McMahon, 2002) strains were ob-
tained from Jackson Laboratories, and the Foxs1lacZ knockin (Heglind et al.,
2005) was kindly provided by Dr S. Enerba¨ck.
All mutants were maintained on C57Bl/6 background (Charles River) with
some 129/SvJ contribution. Experiments were approved by the Gothenburg
Animal Ethics Committee.
Pericyte Quantification and Proliferation Assay
Brains from Foxs1lacZ/+ embryos, or adults, were fixed in 4% paraformalde-
hyde (trans-cardiac perfusion for E18.5 and adults), stained with X-gal accord-
ing to Hogan et al. (1994), and sectioned (paraffin, 6 mm). Brain pericytes were
quantified by counting b-gal+ cells in the brain parenchyma in several match-
ing pairs of sections from mutant and wild-type (three or more individuals per
genotype). To quantify proliferation, the dam was injected with BrdU (Sigma-
Aldrich; 100 mg/g body weight) 1 hr prior to euthanasia, and the percentage
of b-gal+ nuclei in the brain that were also BrdU+ was compared between lit-
termates of different genotype.
BBB Permeability Assays
Evans blue (Sigma-Aldrich, 1% in PBS) was injected intraperitoneally 3 hr
(E18.5, in utero) or 6 hr (adults) before euthanasia. After trans-cardiac perfusion
with PBS, the brain was homogenized in NN-dimethylformamide, and Evans
blue concentration was measured as A620, according to Su et al. (2008).
HRP (Sigma Aldrich; 0.5 mg/g body weight) was injected through the tail
vein and allowed to circulate for 15 min before euthanasia and perfusion fixa-
tion. DAB cytochemistry on brain vibratome sections, followed by TEM, was
performed according to Karnovsky (1967).
Immunodetection and In Situ Hybridization
The anti-Foxf2 antibody HPA004763 is an affinity-purified antibody from the
Human Protein Atlas Project (Nik et al., 2013; Ponte´n et al., 2008). For other pri-
mary antibodies used for IHC, immunofluorescence, and western blot,
together with details on methods and detection systems, see Supplemental
Experimental Procedures. In situ hybridization with 35S-labeled RNA probe
on sections counterstained with Richardson’s methylene blue/azur II was per-
formed according to Angerer and Angerer (1992) and whole-mount in situ hy-
bridization/vibratome sectioning according to Landgren and Carlsson (2004).
Tissues were processed for TEM as previously described (Blixt et al., 2007).
qPCR
cDNA was synthesized (Transcriptor First Strand cDNA Synthesis Kit; Roche)
from total RNA prepared from E18.5 or adult brain (GenElute Mammalian Total
RNAMiniprep Kit; Sigma-Aldrich) and analyzed by SYBRGreen qPCR (5xHOT
FIREPol EvaGreen qPCR Mix Plus [ROX]; SOLIS) in triplicate. Ct values were
normalized against the 36B4 transcript (Akamine et al., 2007). For primer se-
quences, see Supplemental Experimental Procedures.
Statistics
ANOVA was used to test how parameters depended on Foxf2 gene dosage
and two-tailed Student’s t tests for pairwise comparisons of means. Data
points were log-transformed (Evans blue) or arcsine-transformed (fractions)
when required to obtain normal distribution. Frequencies of pericyte nuclei
in TEM sections were tested with c2 analysis.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and six figures and can be found with this article online at http://dx.doi.org/
10.1016/j.devcel.2015.05.008.
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